International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(24), С. 16181 - 16181
Опубликована: Дек. 19, 2022
The
use
of
Cannabis
for
medicinal
purposes
has
been
documented
since
ancient
times,
where
one
its
principal
cannabinoids
extracted
from
sativa,
cannabidiol
(CBD),
emerged
over
the
last
few
years
as
a
promising
molecule
with
anti-seizure
potential.
Here,
we
present
an
overview
recent
literature
pointing
out
CBD's
pharmacological
profile
(solubility,
metabolism,
drug-drug
interactions,
etc.,),
interactions
multiple
molecular
targets
well
advances
in
preclinical
research
concerning
effect
on
both
acute
seizure
models
and
chronic
epilepsy.
We
also
highlight
attention
that
given
to
other
natural
synthetic
derivatives
CBD
possible
compounds
therapeutic
All
scientific
reviewed
here
encourages
continue
investigate
probable
efficacy
related
not
only
epilepsy
but
specially
drug-resistant
epilepsy,
there
is
dire
need
new
effective
drugs
treat
this
disease.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(21), С. 13216 - 13216
Опубликована: Окт. 30, 2022
Primary
mitochondrial
diseases
are
relatively
common
inborn
errors
of
energy
metabolism,
with
a
combined
prevalence
1
in
4300.
These
disorders
typically
affect
tissues
high
requirements,
including
the
brain.
Epilepsy
affects
>1%
worldwide
population,
making
it
one
most
neurological
illnesses;
may
be
presenting
feature
disease,
but
is
often
part
multisystem
clinical
presentation.
The
major
genetic
causes
epilepsy
mutations
DNA
and
nuclear-encoded
gene
POLG.
Treatment
challenging,
representing
poor
prognostic
feature.
This
narrative
review
will
cover
recent
advances
field
epilepsy,
from
pathophysiology
etiologies
to
phenotype
treatment
options.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(18), С. 9975 - 9975
Опубликована: Сен. 16, 2024
Mitochondria
are
a
unique
type
of
semi-autonomous
organelle
within
the
cell
that
carry
out
essential
functions
crucial
for
cell's
survival
and
well-being.
They
location
where
eukaryotic
cells
energy
metabolism.
Aside
from
producing
majority
ATP
through
oxidative
phosphorylation,
which
provides
cellular
functions,
mitochondria
also
participate
in
other
metabolic
processes
cell,
such
as
electron
transport
chain,
citric
acid
cycle,
β-oxidation
fatty
acids.
Furthermore,
regulate
production
elimination
ROS,
synthesis
nucleotides
amino
acids,
balance
calcium
ions,
process
death.
Therefore,
it
is
widely
accepted
mitochondrial
dysfunction
factor
causes
or
contributes
to
development
advancement
various
diseases.
These
include
common
systemic
diseases,
aging,
diabetes,
Parkinson's
disease,
cancer,
well
rare
disorders,
like
Kearns-Sayre
syndrome,
Leigh
myopathy.
This
overview
outlines
mechanisms
by
involved
numerous
illnesses
physiological
activities.
Additionally,
new
discoveries
regarding
involvement
both
disorders
maintenance
good
health.
Mitochondrion,
Год журнала:
2023,
Номер
72, С. 84 - 101
Опубликована: Авг. 13, 2023
Over
65
million
people
suffer
from
recurrent,
unprovoked
seizures.
The
lack
of
validated
biomarkers
specific
for
myriad
forms
epilepsy
makes
diagnosis
challenging.
Diagnosis
and
monitoring
childhood
add
to
the
need
non-invasive
biomarkers,
especially
when
evaluating
antiseizure
medications.
Although
underlying
mechanisms
epileptogenesis
are
not
fully
understood,
evidence
mitochondrial
involvement
is
substantial.
Seizures
affect
35%-60%
patients
diagnosed
with
diseases.
Mitochondrial
dysfunction
pathophysiological
in
various
epilepsies,
including
those
non-mitochondrial
origin.
Decreased
ATP
production
caused
by
malfunctioning
brain
cell
mitochondria
leads
altered
neuronal
bioenergetics,
metabolism
neurological
complications,
Iron-dependent
lipid
peroxidation
initiates
ferroptosis,
a
death
pathway
that
aligns
morphology
found
neurodegenerative
diseases
(NDDs).
Studies
mouse
genetic
models
seizure
phenotypes
where
function
an
essential
selenoprotein
(GPX4)
targeted
suggest
roles
ferroptosis
epilepsy.
GPX4
pivotal
NDDs,
selenium
protects
interneurons
ferroptosis.
Selenium
central
nervous
system
micronutrient
trace
element.
Low
serum
concentrations
other
elements
minerals,
iron,
noted
diagnosing
supplements
alleviate
intractable
seizures
children
reduced
GPX
activity.
Copper
cuproptosis,
like
iron
link
NDDs.
Connecting
these
mechanistic
pathways
selenoproteins
provides
new
insights
into
treating
seizures,
pointing
using
medicines
prodrugs
lipoic
acid
treat
potential
alternative
therapeutic
approaches
transcranial
magnetic
stimulation
(transcranial),
photobiomodulation
vagus
nerve
stimulation.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Фев. 25, 2025
Epilepsy
is
a
neurological
disorder
that
major
cause
of
disability
in
the
world.
This
most
severe
medical
condition
related
with
different
ion
channel
genes,
inflammatory
molecules
depression
and
stress.
For
this
purpose,
precise
diagnostic
techniques
are
available.
Genetic
polymorphisms
factors
behind
occurrence
many
disorders
therefore
they
can
be
valid
for
purpose.
study
emphasis
finding
such
markers
Lahore
population.
Epilepsy-causing
gene
GABRG2
was
selected,
then
examined
to
detect
presence
polymorphic
help
molecular
(PCR)
computational
analysis.
50
blood
samples
epilepsy
patients
were
collected
from
Children
hospital
Lahore,
out
which
2
shown
positive
response
gene,
indicating
becoming
seizures
patients.
These
underwent
mutational
screening,
revealed
6
new
mutations
exon
3
region
these
as
result
disease
occurrence.
There
no
proper
treatments
offered
despite
development
anti-leptic
anti-seizure
drugs.
To
solve
issue,
researchers
working
create
innovative
methods
treating
epilepsy,
incorporate
use
herbal
remedies.
31
plant
compounds
have
been
used
but
only
one
compound
cyanidin
selected
on
base
best
binding
affinity.
Moreover,
SwissAdme,
QSAR
analysis
simulations
demonstrated
natural
drug
model
responses
compared
other
epileptic
drugs
tested
future
application
laboratories.
Leigh
syndrome
(LS)
is
an
inherited
form
of
mitochondrial
encephalopathy
associated
with
various
gene
mutations
the
oxidative
phosphorylation
system,
typically
occurring
in
infancy
or
early
childhood
and
resulting
disability
even
death.
However,
few
late-onset
cases
have
been
reported.
The
objective
this
case
report
was
to
investigate
radiological
clinical
characteristics
adult
patient
diagnosed
syndrome.
This
article
describes
a
who
presented
recurrent
generalized
seizures,
peripheral
neuropathy
hypertension
ultimately
variant,
c.9176T
>
C
(p.Leu217Pro),
20,315
MT-ATP6
gene.
Here,
we
discuss
possible
pathogenesis
its
manifestations
according
related
literature
review
current
therapeutic
approaches
prognosis
LS.
A
diagnosis
LS
should
be
taken
into
consideration
when
patients
characteristic
neuroimaging
findings
demonstrate
neuropathy,
hypertension,
genetic
analysis
carried
out
for
differential
diagnosis.